These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 16060137

  • 1. Effects of combined endothelin and angiotensin II antagonism on growth factor-induced proliferation of vascular smooth muscle cells isolated from uremic rats.
    Wolf SC, Sauter G, Risler T, Brehm BR.
    Ren Fail; 2005; 27(4):465-74. PubMed ID: 16060137
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M, Rodrigue ME, Agharazii M, Larivière R.
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [Abstract] [Full Text] [Related]

  • 4. Effects of combined endothelin A receptor and renin-angiotensin system blockade on the course of end-organ damage in 5/6 nephrectomized Ren-2 hypertensive rats.
    Vaněčková I, Kujal P, Husková Z, Vaňourková Z, Vernerová Z, Certíková Chábová V, Skaroupková P, Kramer HJ, Tesař V, Červenka L.
    Kidney Blood Press Res; 2012 Dec; 35(5):382-92. PubMed ID: 22487948
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Influence of specific and non-specific endothelin receptor antagonists on renal morphology in rats with surgical renal ablation.
    Nabokov A, Amann K, Wagner J, Gehlen F, Münter K, Ritz E.
    Nephrol Dial Transplant; 1996 Mar; 11(3):514-20. PubMed ID: 8671823
    [Abstract] [Full Text] [Related]

  • 7. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A, Veksler S, Gafter U, Boner G, Wittenberg C, van Dijk DJ.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Endothelin receptor antagonists influence cardiovascular morphology in uremic rats.
    Nabokov AV, Amann K, Wessels S, Münter K, Wagner J, Ritz E.
    Kidney Int; 1999 Feb; 55(2):512-9. PubMed ID: 9987075
    [Abstract] [Full Text] [Related]

  • 12. Effects of ACE inhibition and bradykinin antagonism on cardiovascular changes in uremic rats.
    Amann K, Gassmann P, Buzello M, Orth SR, Törnig J, Gross ML, Magener A, Mall G, Ritz E.
    Kidney Int; 2000 Jul; 58(1):153-61. PubMed ID: 10886560
    [Abstract] [Full Text] [Related]

  • 13. Cudraflavanone A, a flavonoid isolated from the root bark of Cudrania tricuspidata, inhibits vascular smooth muscle cell growth via an Akt-dependent pathway.
    Han HJ, Kim TJ, Jin YR, Hong SS, Hwang JH, Hwang BY, Lee KH, Park TK, Yun YP.
    Planta Med; 2007 Sep; 73(11):1163-8. PubMed ID: 17713875
    [Abstract] [Full Text] [Related]

  • 14. Somatostatin sst5 inhibition of receptor mediated regeneration of rat aortic vascular smooth muscle cells.
    Lauder H, Sellers LA, Fan TP, Feniuk W, Humphrey PP.
    Br J Pharmacol; 1997 Oct; 122(4):663-70. PubMed ID: 9375962
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice.
    Bro S, Binder CJ, Witztum JL, Olgaard K, Nielsen LB.
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1080-6. PubMed ID: 17347482
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.
    Mizobuchi M, Morrissey J, Finch JL, Martin DR, Liapis H, Akizawa T, Slatopolsky E.
    J Am Soc Nephrol; 2007 Jun; 18(6):1796-806. PubMed ID: 17513326
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of cardiovascular cell proliferation by angiotensin receptor blockers: are all molecules the same?
    Benson SC, Iguchi R, Ho CI, Yamamoto K, Kurtz TW.
    J Hypertens; 2008 May; 26(5):973-80. PubMed ID: 18398340
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.
    Min LJ, Mogi M, Iwanami J, Li JM, Sakata A, Fujita T, Tsukuda K, Iwai M, Horiuchi M.
    Cardiovasc Res; 2007 Dec 01; 76(3):506-16. PubMed ID: 17706954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.